Literature DB >> 22718821

Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1.

Daniel Malouli1, Ernesto S Nakayasu, Kasinath Viswanathan, David G Camp, W L William Chang, Peter A Barry, Richard D Smith, Klaus Früh.   

Abstract

Cytomegaloviruses are highly host restricted, resulting in cospeciation with their hosts. As a natural pathogen of rhesus macaques (RM), rhesus cytomegalovirus (RhCMV) has therefore emerged as a highly relevant experimental model for pathogenesis and vaccine development due to its close evolutionary relationship to human CMV (HCMV). Most in vivo experiments performed with RhCMV employed strain 68-1 cloned as a bacterial artificial chromosome (BAC). However, the complete genome sequence of the 68-1 BAC has not been determined. Furthermore, the gene content of the RhCMV genome is unknown, and previous open reading frame (ORF) predictions relied solely on uninterrupted ORFs with an arbitrary cutoff of 300 bp. To obtain a more precise picture of the actual proteins encoded by the most commonly used molecular clone of RhCMV, we reevaluated the RhCMV 68-1 BAC genome by whole-genome shotgun sequencing and determined the protein content of the resulting RhCMV virions by proteomics. By comparing the RhCMV genome to those of several related Old World monkey (OWM) CMVs, we were able to filter out many unlikely ORFs and obtain a simplified map of the RhCMV genome. This comparative genomics analysis suggests a high degree of ORF conservation among OWM CMVs, thus decreasing the likelihood that ORFs found only in RhCMV comprise true genes. Moreover, virion proteomics independently validated the revised ORF predictions, since only proteins that were conserved across OWM CMVs could be detected. Taken together, these data suggest a much higher conservation of genome and virion structure between CMVs of humans, apes, and OWMs than previously assumed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718821      PMCID: PMC3416160          DOI: 10.1128/JVI.01132-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  Isolation and characterization of cynomolgus macaque (Macaca fascicularis) cytomegalovirus (CyCMV).

Authors:  Aruna P N Ambagala; Angie Marsh; Jacqueline Chan; Richard Pilon; Jocelyn Fournier; Tony Mazzulli; Paul Sandstrom; David O Willer; Kelly S MacDonald
Journal:  Virology       Date:  2011-01-26       Impact factor: 3.616

2.  All is fair in virus-host interactions: NK cells and cytomegalovirus.

Authors:  Marina Babić; Astrid Krmpotić; Stipan Jonjić
Journal:  Trends Mol Med       Date:  2011-08-17       Impact factor: 11.951

Review 3.  Update on the current status of cytomegalovirus vaccines.

Authors:  Heungsup Sung; Mark R Schleiss
Journal:  Expert Rev Vaccines       Date:  2010-11       Impact factor: 5.217

4.  Genomic sequencing and characterization of cynomolgus macaque cytomegalovirus.

Authors:  Angie K Marsh; David O Willer; Aruna P N Ambagala; Misko Dzamba; Jacqueline K Chan; Richard Pilon; Jocelyn Fournier; Paul Sandstrom; Michael Brudno; Kelly S MacDonald
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

5.  Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs.

Authors:  Ramazan Atalay; Albert Zimmermann; Markus Wagner; Eva Borst; Christine Benz; Martin Messerle; Hartmut Hengel
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

6.  Protein coding content of the UL)b' region of wild-type rhesus cytomegalovirus.

Authors:  Kristie L Oxford; Meghan K Eberhardt; Kai-Wen Yang; Lisa Strelow; Suzanne Kelly; Shan-Shan Zhou; Peter A Barry
Journal:  Virology       Date:  2008-02-20       Impact factor: 3.616

7.  Replication of rhesus cytomegalovirus in life-expanded rhesus fibroblasts expressing human telomerase.

Authors:  W L William Chang; Veronica Kirchoff; Gregory S Pari; Peter A Barry
Journal:  J Virol Methods       Date:  2002-07       Impact factor: 2.014

8.  Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types.

Authors:  Anders E Lilja; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-08       Impact factor: 11.205

9.  Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141.

Authors:  Peter Tomasec; Eddie C Y Wang; Andrew J Davison; Borivoj Vojtesek; Melanie Armstrong; Cora Griffin; Brian P McSharry; Rebecca J Morris; Sian Llewellyn-Lacey; Carole Rickards; Akio Nomoto; Christian Sinzger; Gavin W G Wilkinson
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

10.  Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome.

Authors:  Mark R Schleiss; Alistair McGregor; K Yeon Choi; Shailesh V Date; Xiaohong Cui; Michael A McVoy
Journal:  Virol J       Date:  2008-11-12       Impact factor: 4.099

View more
  25 in total

Review 1.  Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.

Authors:  Hunter K Roark; Jennifer A Jenks; Sallie R Permar; Mark R Schleiss
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

2.  Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunity.

Authors:  Emily E Marshall; Daniel Malouli; Scott G Hansen; Roxanne M Gilbride; Colette M Hughes; Abigail B Ventura; Emily Ainslie; Andrea N Selseth; Julia C Ford; David Burke; Craig N Kreklywich; Jennie Womack; Alfred W Legasse; Michael K Axthelm; Christoph Kahl; Daniel Streblow; Paul T Edlefsen; Louis J Picker; Klaus Früh
Journal:  Sci Transl Med       Date:  2019-07-17       Impact factor: 17.956

3.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

4.  Coding potential of UL/b' from the initial source of rhesus cytomegalovirus Strain 68-1.

Authors:  Rachel B Gill; J Jason Bowman; Tammy Krogmann; Kurt Wollenberg; David M Asher; Jeffrey I Cohen
Journal:  Virology       Date:  2013-10-02       Impact factor: 3.616

5.  Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.

Authors:  Philipp Kolb; Steven Sijmons; Matthew R McArdle; Husam Taher; Jennie Womack; Colette Hughes; Abigail Ventura; Michael A Jarvis; Christiane Stahl-Hennig; Scott Hansen; Louis J Picker; Daniel Malouli; Hartmut Hengel; Klaus Früh
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

6.  Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.

Authors:  Scott G Hansen; Jonah B Sacha; Colette M Hughes; Julia C Ford; Benjamin J Burwitz; Isabel Scholz; Roxanne M Gilbride; Matthew S Lewis; Awbrey N Gilliam; Abigail B Ventura; Daniel Malouli; Guangwu Xu; Rebecca Richards; Nathan Whizin; Jason S Reed; Katherine B Hammond; Miranda Fischer; John M Turner; Alfred W Legasse; Michael K Axthelm; Paul T Edlefsen; Jay A Nelson; Jeffrey D Lifson; Klaus Früh; Louis J Picker
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

7.  The Human Cytomegalovirus UL116 Gene Encodes an Envelope Glycoprotein Forming a Complex with gH Independently from gL.

Authors:  Stefano Caló; Mirko Cortese; Claudio Ciferri; Luca Bruno; Rachel Gerrein; Barbara Benucci; Giuseppina Monda; Michela Gentile; Tobias Kessler; Yasushi Uematsu; Domenico Maione; Anders E Lilja; Andrea Carfí; Marcello Merola
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

Review 8.  Functional genomics approaches to understand cytomegalovirus replication, latency and pathogenesis.

Authors:  Igor Landais; Jay A Nelson
Journal:  Curr Opin Virol       Date:  2013-06-29       Impact factor: 7.090

Review 9.  Development of replication-competent viral vectors for HIV vaccine delivery.

Authors:  Christopher L Parks; Louis J Picker; C Richter King
Journal:  Curr Opin HIV AIDS       Date:  2013-09       Impact factor: 4.283

10.  A seroprevalence study of primate workers for asymptomatic rhesus cytomegalovirus infection.

Authors:  J Jason Bowman; Peter D Burbelo; Rachel B Gill; Michael A Sauri; James M Schmitt; Jeffrey I Cohen
Journal:  J Clin Virol       Date:  2014-06-02       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.